Emergent BioSolutions
EBS
#6766
Rank
ยฃ0.47 B
Marketcap
ยฃ8.93
Share price
-1.24%
Change (1 day)
24.56%
Change (1 year)

Emergent BioSolutions (EBS) - Total debt

Total debt on the balance sheet as of September 2025 : ยฃ0.49 Billion

According to Emergent BioSolutions 's latest financial reports the company's total debt is ยฃ0.49 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Emergent BioSolutions - Total debt on balance sheet (from 2004 to 2025)

Total debt by year

Year Total debt Change
2024-12-31ยฃ0.52 B-21.67%
2023-12-31ยฃ0.67 B-41.89%
2022-12-31ยฃ1.16 B86.51%
2021-12-31ยฃ0.62 B-2.92%
2020-12-31ยฃ0.64 B3.73%
2019-12-31ยฃ0.61 B-1.16%
2018-12-31ยฃ0.62 B6166.84%
2017-12-31ยฃ9.98 M-95.4%
2016-12-31ยฃ0.21 B30.41%
2015-12-31ยฃ0.16 B3.34%
2014-12-31ยฃ0.16 B328.92%
2013-12-31ยฃ37.58 M-3.22%
2012-12-31ยฃ38.83 M1.53%
2011-12-31ยฃ38.25 M24.51%
2010-12-31ยฃ30.72 M-24.35%
2009-12-31ยฃ40.61 M4.09%
2008-12-31ยฃ39.01 M33.79%
2007-12-31ยฃ29.16 M33.55%
2006-12-31ยฃ21.83 M216.16%
2005-12-31ยฃ6.9 M3.05%
2004-12-31ยฃ6.7 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Merck
MRK
ยฃ31.05 B 6,139.48%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
ยฃ0.43 M-99.91%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
ยฃ17.91 B 3,498.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
ยฃ1.96 M-99.60%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ45.67 B 9,076.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ12.81 B 2,474.72%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
ยฃ0.28 M-99.94%๐Ÿ‡บ๐Ÿ‡ธ USA